Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
Hostname: page-component-ffbbcc459-gmk6f Total loading time: 0.339 Render date: 2022-03-07T10:05:33.316Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }
  • English
International Psychogeriatrics International Psychogeriatrics

Article contents

Trajectories of cognitive decline in Alzheimer's disease

Published online by Cambridge University Press:  28 September 2009

Patricia A. Wilkosz ,
Howard J. Seltman ,
Bernie Devlin ,
Elise A. Weamer ,
Oscar L. Lopez ,
Steven T. DeKosky  and
Robert A. Sweet
Patricia A. Wilkosz
Affiliation:
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Howard J. Seltman
Affiliation:
Department of Statistics, Carnegie Mellon University, Pittsburgh, PA, U.S.A.
Bernie Devlin
Affiliation:
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Elise A. Weamer
Affiliation:
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, U.S.A. Department of Neurology, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Oscar L. Lopez
Affiliation:
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, U.S.A. Department of Neurology, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Steven T. DeKosky
Affiliation:
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, U.S.A. Department of Neurology, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Robert A. Sweet*
Affiliation:
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, U.S.A. Department of Neurology, University of Pittsburgh, Pittsburgh, PA, U.S.A. VISN 4 Mental Illness Research, Education and Clinical Center (MIRECC), VA Pittsburgh Healthcare System, Pittsburgh, PA, U.S.A.
*
Correspondence should be addressed to: Robert A. Sweet, M. D., Professor of Psychiatry and Neurology, University of Pittsburgh, Biomedical Science Tower, Rm W-1645, 3811 O'Hara Street, Pittsburgh, PA 15213–2593, U.S.A. Phone +1 412 383 8548; Fax +1 412 624 9910. Email: sweetra@upmc.edu.
Get access Rights & Permissions[Opens in a new window]

Abstract

Background: Late-onset Alzheimer disease (LOAD) is a clinically heterogeneous complex disease defined by progressively disabling cognitive impairment. Psychotic symptoms which affect approximately one-half of LOAD subjects have been associated with more rapid cognitive decline. However, the variety of cognitive trajectories in LOAD, and their correlates, have not been well defined. We therefore used latent class modeling to characterize trajectories of cognitive and behavioral decline in a cohort of AD subjects.

Methods: 201 Caucasian subjects with possible or probable Alzheimer's disease (AD) were evaluated for cognitive and psychotic symptoms at regular intervals for up to 13.5 years. Cognitive symptoms were evaluated serially with the Mini-mental State Examination (MMSE), and psychotic symptoms were rated using the CERAD behavioral rating scale (CBRS). Analyses undertaken were latent class mixture models of quadratic trajectories including a random intercept with initial MMSE score, age, gender, education, and APOE ϵ4 count modeled as concomitant variables. In a secondary analysis, psychosis status was also included.

Results: AD subjects showed six trajectories with significantly different courses and rates of cognitive decline. The concomitant variables included in the best latent class trajectory model were initial MMSE and age. Greater burden of psychotic symptoms increased the probability of following a trajectory of more rapid cognitive decline in all age and initial MMSE groups. APOE ϵ4 was not associated with any trajectory.

Conclusion: Trajectory modeling of longitudinal cognitive and behavioral data may provide enhanced resolution of phenotypic variation in AD.

Keywords

late-onset Alzheimer disease (LOAD)psychosiscognitive neuropsychology in dementiaassessment of cognitive disorders/dementiaAPOE ϵ4
Type
Research Article
Information
International Psychogeriatrics , Volume 22 , Issue 2 , March 2010 , pp. 281 - 290
Copyright
Copyright © International Psychogeriatric Association 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bacanu, S. A., Devlin, B., Chowdari, K. V., DeKosky, S. T., Nimgaonkar, V. L. and Sweet, R. A. (2005). Heritability of psychosis in Alzheimer disease. American Journal of Geriatric Psychiatry, 13, 624–627.CrossRefGoogle ScholarPubMed
Barnes, L. L., Wilson, R. S., Schneider, J. A., Bienias, J. L., Evans, D. A. and Bennett, D. A. (2003). Gender, cognitive decline, and risk of AD in older persons. Neurology, 60, 1777–1781.CrossRefGoogle ScholarPubMed
Berg, L. et al. (1998). Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Archives of Neurology, 55, 326–335.CrossRefGoogle ScholarPubMed
Bertram, K., McQueen, M. B., Mullin, K., Blacker, D. and Tanzi, R. E. (2007). Systematic Meta-Analysis of Alzheimer Disease Genetic Association Studies: The AlzGene Database. Nature Genetics, 39, 17–23.CrossRefGoogle ScholarPubMed
Bretsky, P., Guralnik, J. M., Launer, L., Albert, M. and Seeman, T. E. (2003). The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60, 1077–1081.CrossRefGoogle ScholarPubMed
Corder, E. H. et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921–923.CrossRefGoogle ScholarPubMed
Craft, S. et al. (1998). Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology, 51, 149–153.CrossRefGoogle ScholarPubMed
Curran, P. J. and Willoughby, M. T. (2003). Implications of latent trajectory models for the study of developmental psychopathology. Development and Psychopathology, 15, 581–612.CrossRefGoogle Scholar
Dodge, H. H., Du, Y., Saxton, J. A. and Ganguli, M. (2006). Cognitive domains and trajectories of functional independence in nondemented elderly persons. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 61, 1330–1337.CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). Mini mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle ScholarPubMed
Gruen, B. and Leisch, F. (2008). FlexMix Version 2: finite mixtures with concomitant variables and varying and constant parameters. Journal of Statistical Software, 28, 1–35.Google Scholar
Healy, D. G. (2006). Case-control studies in the genomic era: a clinician's guide. Lancet Neurology, 5, 701–707.CrossRefGoogle ScholarPubMed
Helgeson, V. S., Snyder, P. and Seltman, H. (2004). Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychology, 23, 3–15.CrossRefGoogle ScholarPubMed
Hollingworth, P. et al. (2007). Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B, 841–848.CrossRefGoogle ScholarPubMed
Holmans, P. et al. (2005). Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 135B, 24–32.CrossRefGoogle ScholarPubMed
Hoyt, B. D., Massman, P. J., Schatschneider, C., Cooke, N. and Doody, R. S. (2005). Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Archives of Neurology, 62, 454–459.CrossRefGoogle ScholarPubMed
Jones, B. L., Nagin, D. S. and Roeder, K. (2001). A SAS procedure based on mixture models for estimating developmental trajectories. Sociological Methods and Research, 29, 374–393.CrossRefGoogle Scholar
Kamboh, M. I., Aston, C. E. and Hamman, R. F. (1995). The relationship of APOE polymorphism and cholesteral levels in normoglycemic and diabetic subjects in biethnic population from the San Luis Valley, Colorado. Atherosclerosis, 112, 145–159.CrossRefGoogle Scholar
Kleiman, T. et al. (2006). Apolipoprotein E ϵ4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dementia and Geriatric Cognitive Disorders, 22, 73–82.CrossRefGoogle ScholarPubMed
Leisch, E. (2004). FlexMix: a general framework for finite mixture models and latent class regression in R. Journal of Statistical Software, 11, 1–18.CrossRefGoogle Scholar
Lopez, O. L., Kuller, L. H., Fitzpatrick, A., Ives, D., Becker, J. T. and Beauchamp, N. (2003). Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology, 22, 1–12.CrossRefGoogle ScholarPubMed
Mann, U. M., Mohr, E., Gearing, M. and Chase, T. N. (1992). Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. Journal of Neurology, Neurosurgery and Psychiatry, 55, 956–959.CrossRefGoogle ScholarPubMed
Martins, C. A., Oulhaj, A., de Jager, C. A. and Williams, J. H. (2005). APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology, 65, 1888–1893.CrossRefGoogle ScholarPubMed
McKeith, I. G. et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113–1124.CrossRefGoogle Scholar
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939–944.CrossRefGoogle ScholarPubMed
O'Hara, R., Sommer, B., Way, N., Kraemer, H. C., Taylor, J. and Murphy, G. (2008). Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein ϵ4 allele. Journal of Psychiatric Research, 42, 199–204.CrossRefGoogle Scholar
R Development Core Team (2007). A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing.Google Scholar
Rasmusson, D. X., Carson, K. A., Brookmeyer, R., Kawas, C. and Brandt, J. (1996). Predicting rate of cognitive decline in probable Alzheimer's disease. Brain and Cognition, 31, 133–147.CrossRefGoogle ScholarPubMed
Ropacki, S. A. and Jeste, D. V. (2005). Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. American Journal of Psychiatry, 162, 2022–2030.CrossRefGoogle ScholarPubMed
Royall, D. R., Palmer, R., Chiodo, L. K. and Polk, M. J. (2005). Normal rates of cognitive change in successful aging: the freedom house study. Journal of the International Neuropsychological Society, 11, 899–909.CrossRefGoogle ScholarPubMed
Scarmeas, N. et al. (2005). Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology, 62, 1601–1608.CrossRefGoogle ScholarPubMed
Schwarz, G. (1978). Estimating the dimension of a model. Annals of Statistics, 6, 461–464.CrossRefGoogle Scholar
Tariot, P. N. et al. (1995). The behavior rating scale for dementia of the Consortium to Establish a Registry for Alzheimer's Disease. American Journal of Psychiatry, 152, 1349–1357.Google ScholarPubMed
Tyas, S. L. et al. (2007). Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. American Journal of Epidemiology, 165, 1231–1238.CrossRefGoogle ScholarPubMed
91
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Trajectories of cognitive decline in Alzheimer's disease
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Trajectories of cognitive decline in Alzheimer's disease
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Trajectories of cognitive decline in Alzheimer's disease
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *